StonvexLoading…
StonvexStonvexStonvexCore line items from AOSL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $696.16M | $657.27M | $691.32M | $777.55M |
Operating Income | $-28.44M | $-3.76M | $22.53M | $102.04M |
Net Income | $-96.98M | $-11.08M | $12.36M | $453.16M |
EPS (Diluted) | $-3.30 | $-0.39 | $0.42 | $16.07 |
Total Assets | $1.03B | $1.15B | $1.20B | $1.30B |
Total Liabilities | $211.97M | $253.41M | $315.82M | $444.54M |
Cash & Equivalents | $153.08M | $175.13M | $195.19M | $314.35M |
Free Cash Flow OCF − CapEx | $-7.51M | $-11.38M | $-89.95M | $80.85M |
Shares Outstanding | 30.01M | 28.97M | 27.65M | 27.37M |